Keymed Biosciences anuncia la aprobación de IND para CM518D1 por parte de la Administración Nacional de Productos Médicos de China para el tratamiento de tumores sólidos CHENGDU, China, 27 de abril de 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" o la "compañía")...
Read More Details
Finally We wish PressBee provided you with enough information of ( Keymed Biosciences anuncia la aprobación de CM518D1 para el tratamiento de tumores sólidos )
Also on site :
- Death toll in Iran port explosion mounts to 25
- Several killed as car rams into crowd at Vancouver festival
- My grandfather survived Nazi concentration camps – now it’s my duty to crush Hamas & save Israel, says Brit dad